Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NCJournal for immunotherapy of cancer

Stereotactic body radiation therapy enriches mediators of humoral immune activity in metastatic renal cell carcinoma.

  • Nicholas J Salgia1,2
  • Adil Khan3
  • Yu Fujiwara4
  • Mark Long5
  • Gavin C Twoey3,6
  • Kyle Leatt3,7
  • Jacky Chow3
  • Scott I Abrams3
  • Thomas Schwaab8
  • Anurag K Singh9
  • Jason B Muhitch1
9 affiliations
  1. 1Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA [email protected] [email protected].
  2. 2Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
  3. 3Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  4. 4Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  5. 5Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  6. 6Department of Microbiology and Immunology, University at Buffalo, Buffalo, New York, USA.
  7. 7Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, New York, USA.
  8. 8Helen F Graham Cancer Center and Research Institute, Newark, Delaware, USA.
  9. 9Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Read full textPDFDOICite

Related

  1. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Emeline Guiard, Florian Clatot, Caroline Even +5
    European Journal of CancerPeer-reviewedPublisher termsFull text20 citedGeneral biologyOncologyHAL
  2. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Emilien Billon, Cécile Dalban, Stephane Oudard +17
    European Urology OncologyPeer-reviewedLicence not stated6 citedGeneral biologyHAL
  3. Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma
    Minchao Qin, Zhongwen Feng, Chao Zhang +3
    PLOS OnePeer-reviewedCC BYFull textGeneral biochemistryCell biologyPLOSEurope PMCPMC
  4. Real-world comparative outcomes of first-line immune combinations (ICI-ICI vs ICI-TKI) in metastatic renal cell carcinoma with sarcomatoid features.
    Sara Elena Rebuzzi, Fabrizio Di Costanzo, Roberto Filippi +46
    OncoimmunologyPeer-reviewedCC BY-NCFull textImmunologyOncologyEurope PMCPMC
  5. SPP1 promotes anoikis resistance and metastatic phenotypes in hepatocellular carcinoma through PI3K-sensitive signaling
    Xinyue Zhang, Honglong Wei, Reguang Pan +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{salgia2026stereotactic,
  title = {{Stereotactic body radiation therapy enriches mediators of humoral immune activity in metastatic renal cell carcinoma.}},
  author = {Nicholas J Salgia and Adil Khan and Yu Fujiwara and Mark Long and Gavin C Twoey and Kyle Leatt and Jacky Chow and Scott I Abrams and Thomas Schwaab and Anurag K Singh and Jason B Muhitch},
  journal = {Journal for immunotherapy of cancer},
  year = {2026},
  month = oct,
  doi = {10.1136/jitc-2026-015849},
  url = {https://europepmc.org/article/MED/42849919},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Stereotactic body radiation therapy enriches mediators of humoral immune activity in metastatic renal cell carcinoma.
AU  - Nicholas J Salgia
AU  - Adil Khan
AU  - Yu Fujiwara
AU  - Mark Long
AU  - Gavin C Twoey
AU  - Kyle Leatt
AU  - Jacky Chow
AU  - Scott I Abrams
AU  - Thomas Schwaab
AU  - Anurag K Singh
AU  - Jason B Muhitch
PY  - 2026
DA  - 2026/10/08
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-015849
UR  - https://europepmc.org/article/MED/42849919
SN  - 2051-1426
ER  -